| 1 | Increased risk of tick-borne diseases with climate and envir… (10.14745/ccdr.v45i04a02) | Abstract References ORCID License | 241.83 | 261 |
| 2 | Motivational interviewing: A powerful tool to address vaccin… (10.14745/ccdr.v46i04a06) | Abstract References ORCID License | 213.35 | 135 |
| 3 | Challenges and opportunities for public health made possible… (10.14745/ccdr.v46i06a02) | Abstract References ORCID License | 207.55 | 118 |
| 4 | Estimated prevalence of Hepatitis C Virus infection in Canad… (10.14745/ccdr.v40i19a02) | Abstract References ORCID License | 200.86 | 101 |
| 5 | Reaping the benefits of Open Data in public health (10.14745/ccdr.v45i10a01) | Abstract References ORCID License | 195.90 | 90 |
| 6 | HIV in Canada—Surveillance Report, 2018 (10.14745/ccdr.v45i12a01) | Abstract References ORCID License | 192.43 | 83 |
| 7 | Big Data and the Global Public Health Intelligence Network (… (10.14745/ccdr.v41i09a02) | Abstract References ORCID License | 190.31 | 79 |
| 8 | Environmental risk from Lyme disease in central and eastern… (10.14745/ccdr.v40i05a01) | Abstract References ORCID License | 188.08 | 75 |
| 9 | HIV in Canada—Surveillance Report, 2017 (10.14745/ccdr.v44i12a03) | Abstract References ORCID License | 186.92 | 73 |
| 10 | Optimizing communication material to address vaccine hesitan… (10.14745/ccdr.v46i23a05) | Abstract References ORCID License | 184.51 | 69 |
| 11 | Barriers to and facilitators of hepatitis C virus screening… (10.14745/ccdr.v44i78a03) | Abstract References ORCID License | 179.24 | 61 |
| 12 | Increased risk of endemic mosquito-borne diseases in Canada… (10.14745/ccdr.v45i04a03) | Abstract References ORCID License | 177.82 | 59 |
| 13 | Climate change and infectious diseases: What can we expect? (10.14745/ccdr.v45i04a01) | Abstract References ORCID License | 175.59 | 56 |
| 14 | Latent tuberculosis infection: An overview (10.14745/ccdr.v43i34a01) | Abstract ORCID License | 175.38 | 217 |
| 15 | Emerging mosquito-borne bunyaviruses in Canada (10.14745/ccdr.v41i06a01) | Abstract References ORCID License | 174.04 | 54 |
| 16 | Vaccine acceptance, hesitancy and refusal in Canada: Challen… (10.14745/ccdr.v42i12a02) | Abstract References ORCID License | 170.76 | 50 |
| 17 | Lyme disease: clinical diagnosis and treatment (10.14745/ccdr.v40i11a01) | Abstract References ORCID License | 169.90 | 49 |
| 18 | Modelling scenarios of the epidemic of COVID-19 in Canada (10.14745/ccdr.v46i06a08) | Abstract References ORCID License | 167.21 | 46 |
| 19 | Tuberculosis in Canada, 2016 (10.14745/ccdr.v44i34a01) | Abstract References ORCID License | 166.28 | 45 |
| 20 | The continued rise of Lyme disease in Ontario, Canada: 2017 (10.14745/ccdr.v44i10a01) | Abstract References ORCID License | 163.35 | 42 |
| 21 | How will climate change impact microbial foodborne disease i… (10.14745/ccdr.v45i04a05) | Abstract References ORCID License | 163.35 | 42 |
| 22 | Tuberculosis in Canada: 2017 (10.14745/ccdr.v45i23a04) | Abstract References ORCID License | 161.28 | 40 |
| 23 | Effectiveness of hand hygiene practices in preventing influe… (10.14745/ccdr.v45i01a02) | Abstract References ORCID License | 159.11 | 38 |
| 24 | Sentinel surveillance of Lyme disease risk in Canada, 2019:… (10.14745/ccdr.v46i10a08) | Abstract References ORCID License | 159.11 | 38 |
| 25 | An overview of foodborne outbreaks in Canada reported throug… (10.14745/ccdr.v41i11a01) | Abstract References ORCID License | 157.98 | 37 |
| 26 | Addressing the rising rates of gonorrhea and drug-resistant… (10.14745/ccdr.v45i23a02) | Abstract References ORCID License | 156.82 | 36 |
| 27 | Canadian results from the European Men-who-have-sex-with-men… (10.14745/ccdr.v45i11a01) | Abstract References ORCID License | 155.63 | 35 |
| 28 | National findings from the Tracks survey of people who injec… (10.14745/ccdr.v46i05a07) | Abstract References ORCID License | 153.15 | 33 |
| 29 | Assessment of a screening test to identify Lyme disease risk (10.14745/ccdr.v40i05a02) | Abstract References ORCID License | 151.85 | 32 |
| 30 | Surveillance for Lyme disease in Canada, 2009 to 2012 (10.14745/ccdr.v41i06a03) | Abstract References ORCID License | 151.85 | 32 |
| 31 | Pertussis Surveillance in Canada: Trends to 2012 (10.14745/ccdr.v40i03a01) | Abstract References ORCID License | 150.51 | 31 |
| 32 | Infectious disease, social determinants and the need for int… (10.14745/ccdr.v42is1a04) | Abstract References ORCID License | 150.51 | 31 |
| 33 | Awareness and knowledge of hepatitis C among health care pro… (10.14745/ccdr.v44i78a02) | Abstract References ORCID License | 150.51 | 31 |
| 34 | Risk assessment strategies for early detection and predictio… (10.14745/ccdr.v45i05a02) | Abstract References ORCID License | 149.14 | 30 |
| 35 | Multidrug-resistant and extensively drug-resistant Neisseria… (10.14745/ccdr.v45i23a01) | Abstract References ORCID License | 149.14 | 30 |
| 36 | Invasive pneumococcal disease surveillance in Canada, 2021–2… (10.14745/ccdr.v50i05a02) | Abstract References ORCID License | 149.14 | 30 |
| 37 | Increase in detection of Corynebacterium diphtheriae in Cana… (10.14745/ccdr.v45i11a04) | Abstract References ORCID License | 147.71 | 29 |
| 38 | Could exotic mosquito-borne diseases emerge in Canada with c… (10.14745/ccdr.v45i04a04) | Abstract References ORCID License | 144.72 | 27 |
| 39 | Fake news and science denier attacks on vaccines. What can y… (10.14745/ccdr.v46i1112a11) | Abstract References ORCID License | 141.50 | 25 |
| 40 | Fifteen years post-SARS: Key milestones in Canada's public h… (10.14745/ccdr.v44i05a01) | Abstract References ORCID License | 139.79 | 24 |
| 41 | The health effects of climate change: Know the risks and bec… (10.14745/ccdr.v45i05a01) | Abstract References ORCID License | 139.79 | 24 |
| 42 | Managing immunization stress-related response: A contributor… (10.14745/ccdr.v46i06a10) | Abstract References ORCID License | 139.79 | 24 |
| 43 | Surveillance for Ixodes scapularis and Ixodes pacificus tick… (10.14745/ccdr.v48i05a04) | Abstract References ORCID License | 139.79 | 24 |
| 44 | Enhanced surveillance of invasive meningococcal disease in C… (10.14745/ccdr.v40i09a01) | Abstract References ORCID License | 138.02 | 23 |
| 45 | Epidemiology of Clostridioides difficile infection in Canada… (10.14745/ccdr.v45i78a04) | Abstract References ORCID License | 138.02 | 23 |
| 46 | National Hepatitis C estimates: Incidence, prevalence, undia… (10.14745/ccdr.v48i1112a07) | Abstract References ORCID License | 138.02 | 23 |
| 47 | Surveillance for Lyme disease in Canada: 2009–2015 (10.14745/ccdr.v43i10a01) | Abstract ORCID License | 137.91 | 68 |
| 48 | CATMAT statement on disseminated strongyloidiasis: Preventio… (10.14745/ccdr.v42i01a03) | Abstract ORCID License | 137.44 | 67 |
| 49 | Rising syphilis rates in Canada, 2011–2020 (10.14745/ccdr.v48i23a01) | References ORCID License | 136.96 | 66 |
| 50 | HIV in Canada—Surveillance Report, 2016 (10.14745/ccdr.v43i12a01) | Abstract ORCID License | 136.47 | 65 |